Skip to main content
. 2010 Oct 29;119(3):326–331. doi: 10.1289/ehp.1002256

Table 1.

Baseline characteristics, overall and by VTE status.

VTE status
Characteristic Overall (n = 26,450) No VTE (n = 25,942) VTE (n = 508)
Age (years) 63.4 ± 7.2 63.4 ± 7.2 66.1 ± 6.6
Race/ethnicity
 Non-Hispanic white 21,609 (81.7) 21,166 (81.6) 443 (87.2)
 Non-Hispanic black 2,699 (10.2) 2,646 (10.2) 53 (10.4)
 Hispanic 1,498 (5.7) 1,491 (5.7) 7 (1.4)
 Other 644 (2.4) 639 (2.5) 5 (1.0)
Education
 Some high school 2,130 (8.0) 2,085 (8.0) 45 (8.9)
 High school graduate 5,454 (20.6) 5,348 (20.6) 106 (20.9)
 Some college 10,733 (40.6) 10,531 (40.6) 202 (39.7)
 ≥ College degree 8,133 (30.8) 7,978 (30.8) 155 (30.5)
BMI (kg/m2) 29.1 ± 6.0 29.1 ± 6.0 31.2 ± 6.6
Coronary heart disease 494 (1.9) 484 (1.9) 10 (2.0)
Peripheral arterial disease 440 (1.7) 429 (1.7) 11 (2.2)
Stroke 294 (1.1) 285 (1.1) 9 (1.8)
Hypercholesterolemia 3,206 (12.1) 3,146 (12.1) 60 (11.8)
Cancer 840 (3.2) 817 (3.1) 23 (4.5)
Fracturea 211 (0.8) 206 (0.8) 5 (1.0)
Aspirin or NSAID use 10,150 (38.4) 9,906 (38.2) 244 (48.0)
Current smoking 2,735 (10.5) 2,693 (10.5) 50 (8.4)
Physical activity (kcal/kg/week) 10.0 ± 11.2 10.0 ± 11.2 8.7 ± 10.6
Randomization status
 E 5,104 (19.3) 4,991 (19.2) 113 (22.2)
 Placebo for E arm 5,228 (19.8) 5,139 (19.8) 89 (17.5)
 E + P 8,255 (31.2) 8,064 (31.1) 191 (37.6)
 Placebo for E + P arm 7,863 (29.7) 7,748 (29.9) 115 (22.6)
Daily temperature (°C) NA NA 13.0 ± 9.5
Season
 January–March NA NA 177 (34.8)
 April–June NA NA 124 (24.4)
 July–September NA NA 150 (29.5)
 October–December NA NA 57 (11.2)
Follow-up time (person-years) 198,048 195,898 2,150

Abbreviations: E, CEE, 0.625 mg/day; E + P, CEE, 0.625 mg/day plus medroxyprogesterone acetate, 0.25 mg/day; NA, not applicable for participants without event. Data are reported as n (%) or mean ± SD. Descriptive data include imputed baseline covariate data.

a

Hip or femur.